Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

San Francisco VA Health Care System


$100,000 Potamkin Prize Awarded to Michael Weiner, MD

Dr. Michael Weiner

Michael W. Weiner, MD

Wednesday, March 13, 2013

Michael W. Weiner, MD, Director, Center for Imaging of Neurodegenerative Diseases at the San Francisco VA Medical Center (SFVAMC), is one of three physicians to be awarded the 2013 Potamkin Prize for Research. The $100,000 prize is an internationally recognized tribute for advancing dementia research.

The Potamkin Prize honors researchers for their work in advancing the understanding of Alzheimer’s disease, Pick’s disease and other related disorders. Weiner is receiving the prize for standardizing imaging and biomarker tests to find better ways to detect and diagnose Alzheimer’s disease. He help formed the Alzheimer’s Disease Neuroimaging Initiative (ADNI), which was the first to perform amyloid positron-emission tomographic (PET) imaging brain scans at multiple sites across the United States. Today, amyloid PET imaging is widely available for diagnosis and use in clinical trials.

“None of this would be possible without SFVAMC’s strong leadership and support,” said Weiner. “ADNI, a $40 million project, is the only scientific project that shares data with the world as we receive it; we do not embargo it. Sharing this information has increased collaboration and research in the area.” 

Weiner, an Air Force Veteran, has published over 630 peer reviewed scientific papers. His grants have included studies of Gulf War illness, post traumatic stress, traumatic brain injury, ALS, epilepsy, Alzheimer’s disease, vascular dementia, front temporal dementia, HIV/AIDS, and other neurodegenerative conditions. In 2006 he received VA’s highest honor for scientific achievement, the William S. Middleton Award, which recognizes senior VA investigators who have achieved international acclaim for research accomplishments in areas of prime importance to VA’s research mission.

“The methods developed by ADNI are now considered the standard for clinical trials,” said Weiner. “Over 1,000 subjects have been enrolled and followed in ADNI. ADNI has led to more than 300 scientific papers, and ADNI projects are ongoing in many countries around the world. I am so grateful to receive this award.”

The Potamkin Prize is made possible by the philanthropic contributions of the Potamkin family of Colorado, Philadelphia and Miami. The goal of the prize is to help attract the best medical minds and most dedicated scientists in the world to the field of dementia research. The Potamkin family has been the Academy’s single largest individual donor since 1988, providing more than $2.5 million to fund the Potamkin Prize.

The American Academy of Neurology, an association of more than 25,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer’s disease, stroke, migraine, multiple sclerosis, brain injury, Parkinson’s disease and epilepsy.

The American Academy of Neurology and the American Brain Foundations will present the award during the Academy’s 65th Annual Meeting to be held March 16-23 in San Diego. Over 10,000 attend the Annual Meeting, the world’s largest gathering of neurologists.

The SFVAMC has the largest medical research program in the national VA system, with more than 200 research scientists, all of whom are faculty members at UCSF.  SFVAMC’s research is in association with its 501c(3) non-profit affiliate, The Northern California Institute for Research and Education (NCIRE – The Veterans Health Research Institute).

UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care.


Get Updates

Subscribe to Receive
Email Updates